According to Reuters, the change was reported on June 2 after employee plan materials showed the new exclusion
International Archives of Allergy and Immunology, 185(8), 803809
Patients taking GLP-1 medications should watch for sudden or unexplained changes in vision, including painless vision loss or blurring in one eye, dimming of vision, changes in color perception, or missing areas in their field of view, according to consultant ophthalmic surgeon Mr
Food Addit Contam (2004) 21:84956
S., Luthra, S., Sandhu, A
Berberine is an unlicensed supplement with modest effects and limited evidence, whilst GLP-1 receptor agonists are rigorously tested, MHRA-licensed medicines with proven efficacy for type 2 diabetes management under medical supervision